Anti-CD5 monoclonal antibodies linked to momordin (a ribosome-inactivating protein purified from M. charantia) performed better than other anti-CD5-based immunoconjugates containing ricin A chain on human T cell leukemia Jurkat. This evidence concerns the gene CD5 and T-cell leukemia.